Bristol Myers Squibb Co. (BMY)
- NYSE: BMY
- Mkt.Cap.:45.87B
Focused: 
Healthcare > Biopharmaceuticals (^BPHRM)
Healthcare > Biopharmaceuticals (^BPHRM) Classification
| Sector | |
|---|---|
 Healthcare |
|
 Biopharmaceuticals |
|
- - Focused
- - Sector Pure-Play
Sector companies
Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :
| Ticker | Name | Mkt.Cap. |
|---|---|---|
| PFE | Pfizer Inc. | 133.11B |
| NVS | Novartis AG (ADR) | 122.38B |
| RHHBY | Roche Holding Ltd. (ADR) | 121.62B |
| MRK | Merck & Co., Inc. | 110.07B |
| GSK | GlaxoSmithKline plc (ADR) | 101.52B |
Relationships
Sample 8 relationships grouped by relationhip type.
| Ticker | Name | |
|---|---|---|
| Competitors | ||
 | ACCP | Access Pharmaceuticals, Inc. |
| ALKS | Alkermes, Inc. |
| Customers | ||
 | ABC | AmerisourceBergen Corp. |
| CAH | Cardinal Health, Inc. |
| Suppliers | ||
| ABT | Abbott Laboratories |
| LLY | Eli Lilly & Co. |
| Partners | ||
| ABT | Abbott Laboratories |
| ABC | AmerisourceBergen Corp. |
- - Defined by the Company
- - Defined by Others
Products & Services
Sample products & services from Biopharmaceuticals (^BPHRM) :
- Abilify (Aripiprazole)/Abilify Discmelt (Aripiprazole Orally Disintegrating Tablet)
- Adnectin (Human Fibronectin)
- Androgen Receptor Antagonists
Relative Performance (1Y)
- Bristol Myers Squibb Co. (BMY)- - S&P 500 INDEX (SPX)
-
- Healthcare > Biopharmaceuticals (^BPHRM)
Subscribe to an RSS Feed Research Reports
- FDA Approval Decisions Report for Apr, 2006 Revere - Apr 01, 2006 - PDF - View Report »
- FDA Approval Decisions Report for Apr, 2008 Revere - Apr 01, 2008 - PDF - View Report »
- FDA Approval Decisions Report for Apr, 2009 Revere - Apr 01, 2009 - PDF - $125.00 - Add to Cart »
- FDA Approval Decisions Report for Aug, 2006 Revere - Aug 01, 2006 - PDF - View Report »
- FDA Approval Decisions Report for Aug, 2007 Revere - Aug 01, 2007 - PDF - View Report »